CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 71 filers reported holding CULLINAN ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $442,889 | -17.7% | 41,980 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $538,000 | +71.9% | 41,980 | +40.3% | 0.00% | – |
| Q1 2022 | $313,000 | -34.2% | 29,930 | -2.9% | 0.00% | – |
| Q4 2021 | $476,000 | -34.6% | 30,820 | -4.4% | 0.00% | -100.0% |
| Q3 2021 | $728,000 | -13.0% | 32,250 | -0.8% | 0.00% | 0.0% |
| Q2 2021 | $837,000 | -42.1% | 32,520 | -6.2% | 0.00% | 0.0% |
| Q1 2021 | $1,445,000 | – | 34,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $69,216,825 | 18.48% |
| CHI Advisors LLC | 3,414,189 | $30,898,410 | 12.25% |
| Nextech Invest Ltd. | 1,221,145 | $11,051,362 | 3.35% |
| TANG CAPITAL MANAGEMENT LLC | 621,138 | $5,621,299 | 0.79% |
| BVF INC/IL | 3,196,701 | $28,930,144 | 0.78% |
| Parkman Healthcare Partners LLC | 438,745 | $3,970,642 | 0.73% |
| Velan Capital Investment Management LP | 75,000 | $678,750 | 0.55% |
| BRAIDWELL LP | 1,908,865 | $17,275,228 | 0.55% |
| Boxer Capital, LLC | 1,074,082 | $9,720,442 | 0.52% |
| DAFNA Capital Management LLC | 127,284 | $1,151,920 | 0.36% |